Responses

Is melatonin likely to help children with neurodevelopmental disability and chronic severe sleep problems?
Free
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Re: Response to Jan et al

    Dear Editor

    We would like to take this opportunity to thank Jan and colleagues for responding to our article. It is acknowledged that the team at the Melatonin Research Group has the longest experience worldwide in the use of melatonin in children with neurodevelopmental disability.

    The paper they refer to [1] includes a randomised controlled trial (RCT) of fast-acting vs. controlled release melatonin. Only the...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Response to is melatonin likely to help children with neurodevelopmental
    • J E Jan, Melatonin Research Group
    • Other Contributors:
      • M Bomben, H Espczel, RD Freeman, M Wasdell, M Weiss

    Dear Editor

    Last year, Archimedes, a new format, was launched by Archives of Disease in Childhood for offering "practical, best evidence based answers to practical, clinical questions". One of the first questions was : "Does melatonin help developmentally delayed children with sleep problems?".[1] Since the conclusions of this brief article are now on the Internet and physicians have access to them, our Melatonin Res...

    Show More
    Conflict of Interest:
    None declared.